comparemela.com
Home
Live Updates
Save The Site Institute - Breaking News
Pages:
Latest Breaking News On - Save the site institute - Page 1 : comparemela.com
Invex Therapeutics opens up more trial sites with second Australian ethics approval
Invex Therapeutics (ASX: IXC) has secured its second Human Research Ethics Committee (HREC) approval in Australia to begin its phase III trial evaluating its lead drug Presendin in patients with idiopathic intracranial hypertension (IIH).
New south wales
United kingdom
Alex sinclair
Clare fraser
Australian therapeutic goods administration
Save the site institute
Human research ethics committee
Ophthalmology society of australia
Ophthalmology virtual education library
Invex therapeutics
Alfred hospital
Sydney eye
Prof alex sinclair
Australian therapeutic goods
Associate prof clare
Site institute
vimarsana © 2020. All Rights Reserved.